TruthArchive.ai - Related Video Feed

This video discusses the history of coronavirus research, highlighting its origins in 1965 and the development of spike protein vaccines by Pfizer in 1990. The speaker emphasizes the long-standing manipulation of pathogens for various purposes and questions the ethical implications of these actions. The conversation urges listeners to consider the implications of such research on humanity's future.

The speaker discusses the use of mRNA in food and mentions a presentation about genetically engineering mosquitoes to deliver vaccines through mosquito bites. They mention that the Gates Foundation is funding this research, although they don't have proof of its viability. The speaker clarifies that they are not suggesting that the mosquitoes are currently injecting anyone with anything, but they have evidence that efforts are being made to enable mosquito injections.

The video discusses various topics related to biotechnology, biomedical technology, and the potential risks associated with biological weapons. It mentions the use of nanotechnology, the development of vaccines, and the role of international cooperation in addressing these issues. The speakers also touch on the possibility of synthetic viruses and the need for ethical governance in research and implementation. Overall, the video emphasizes the importance of understanding and managing the risks associated with biotechnology for the benefit of society.

mRNA technology, used in COVID vaccines, raises ethical concerns about potential control. Multiple genes and regulatory elements can be inserted, allowing for different vaccinations and antigens to be regulated. This could lead to unknown protein expression when consuming certain foods. S. Matthew Liao, a philosopher, suggests using human engineering to address global issues like meat consumption. By making people intolerant to certain proteins, it could reduce meat consumption and benefit the planet. Doctor Christina Parkes expresses ethical concerns about the regulation of genetic information through hormones, airborne substances, and the food supply. These discussions highlight the potential dangers and ethical implications of mRNA technology and human engineering.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

Technology is being rapidly advanced and implemented in humans, particularly messenger RNA vaccines. These advancements are being fast-tracked, and it's important to acknowledge that our food species will also be affected by these vaccines.

The video discusses the different processes used to create COVID-19 vaccines, specifically the mRNA vaccines from Moderna and Pfizer. The first process, called Process 1, involved a synthetic PCR method and was tested on 40,000 people. However, a second process, tested on only 252 people, was used to produce vaccines for billions of people. This second process involved using a complementary DNA sequence to make the mRNA. It is revealed that this process was not properly tested and resulted in bacterial plasmid DNA contamination in the vaccines. The presence of this contamination raises concerns about potential long-term effects, such as autoimmune diseases and cancers. The video criticizes the fact that contaminated products are still being distributed despite the risks involved.

YouTube censorship and the use of genetic vaccines are discussed in this video. The speaker, a researcher in biological and medical sciences, claims that genetic vaccines can lead to the emergence of recombinant viruses. They explain that recombinant viruses are a mix of genetic material from two parental viruses, but co-infection with two viruses is unlikely. The speaker also argues that mass vaccination with genetic vaccines can contribute to the selection of variant viruses. They personally choose not to get vaccinated against COVID-19, believing it is the responsibility of non-vulnerable individuals to refrain from vaccination. They suggest that convincing older individuals to get vaccinated is difficult due to a lack of persuasive arguments.

In Chicago's manufacturing facility, a new type of vaccine is being developed using a technology called virus like particles. Medicago, the company behind it, uses plants as mini bioreactors. They start by synthesizing the gene sequence of a virus into a biological product. The plants absorb this information through a bath with bacteria, which is then replaced with liquid using a vacuum. After spending at least 4 days in a controlled greenhouse, the plants begin producing virus like particles, the key ingredient for the vaccines.

The speaker states that mRNA in food is a critical issue, but also highlights the potential for transgenic mosquitoes to deliver vaccines via saliva. They reference a presentation about producing a transgenic mosquito as a "flying syringe" to deliver protective vaccines. The speaker claims the Gates Foundation is funding genetic engineering of mosquitoes with the intention of using mosquito bites for vaccination. While they don't have definitive proof of its viability, they assert that this research is underway. The speaker clarifies they are not claiming current mosquitoes are injecting people with anything. However, they state they have indisputable evidence that efforts are being made to enable mosquitoes to inject people with substances in the future.

A bill in Tennessee proposes labeling food with vaccines, while Idaho has a similar bill. Edible vaccines are being studied at UC Riverside, where scientists are exploring the use of plants like lettuce to produce mRNA vaccines. Traditionally, vaccines are grown in eggs or animal cells, but plant-based vaccines are being developed. Genetic editing is being used to create edible vaccines in plants like bananas, potatoes, tomatoes, lettuce, rice, wheat, soybeans, and corn. Medicago is using gene editing to turn plants into mini bioreactors for vaccine production. There are concerns about mRNA vaccines being used on livestock, with the potential for transference to humans through meat consumption. Transparency laws are being debated to inform consumers about genetically modified products in livestock.

Scientists are using CRISPR technology to edit the genes of microbiomes, which are tiny microbes that live in and on our bodies. By editing these microbiomes, they hope to address various health issues and even combat climate change. However, concerns have been raised about the potential risks and ethical implications of this technology. Additionally, the video discusses the awarding of the Nobel Prize in Medicine to scientists who developed mRNA vaccines for COVID-19, questioning the effectiveness of these vaccines and highlighting hidden COVID-19 cases among vaccinated individuals. It also mentions China's experiments with gene editing and the potential creation of radiation-resistant super soldiers. The video concludes by promoting the importance of food security and investing in gold and silver.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

I've been involved in over 50 vaccines, including mRNA vaccines. mRNA is like DNA, giving cells instructions to make proteins. This technology was originally for gene therapy, now used for vaccines. It's a new, experimental technology never used in humans before COVID. Animal studies were skipped for COVID vaccines, a novel approach.

In this video, the speaker discusses the challenges of eradicating malaria and the potential use of genetically modified mosquitoes to deliver vaccines. They express concerns about the spread of malaria if the genetic modification fails and question the ethical implications of releasing modified mosquitoes without informed consent. Another speaker highlights the importance of considering climate change and its impact on the geographic range of disease-carrying mosquitoes. They emphasize the need to prevent, prepare for, and respond to emerging pathogens, using the systems and tools developed for COVID-19 as examples. The speaker also mentions the efforts made by countries to strengthen their healthcare systems for various diseases.

In this video, the speaker discusses the presence of DNA fragments in COVID mRNA vaccines. They mention that while it has been proven in the laboratory, it hasn't been solidly proven in real-life human beings. The speaker criticizes certain individuals for not responding to their communications over the past two years. They also claim that the vaccine has caused a high number of deaths and injuries. The speaker suggests that people should be aware of the corruption in healthcare systems and recommends using products from a wellness company. The video concludes with a promotion for the wellness company's medical emergency kit.

This video provides a comprehensive overview of the problems and potential risks associated with mRNA vaccines. The speaker identifies five main issues with the current technology, including dose, pharmacokinetics, localization, fidelity, and innate immunity. They argue that the technology is not yet fully understood or controlled, and that it has been introduced prematurely. The speaker also highlights the lack of tools to measure the production and distribution of the vaccine in the body, as well as potential risks and side effects. They discuss modifications made to the mRNA sequence and how they can impact protein production. The speaker also mentions the potential for immune system suppression and increased risk of infections, parasites, and cancers due to the inhibition of innate immunity. The lack of transparency and proper regulation in the approval process for these vaccines is criticized, and the need for further research and long-term monitoring of their effects is emphasized.

In this video, the speaker discusses the possibility of future pandemics and the importance of being prepared. They mention that plant-based extracts, such as Negarinin found in grapefruits and tomatoes, can block the entry of viruses like Ebola and Marburg into human cells. They also talk about the Marburg virus, which is similar to boomslang snake venom and could potentially be used as a biological weapon. The speaker suggests that high-dose vitamin C can be inhibitory to snake venoms and mentions a movie called "Bullet Train" that references the boomslang snake. They believe that Hollywood and a TV show called "Blacklist" have hinted at the narrative of COVID-19.

This video discusses the coronavirus and the ongoing research programs to develop vaccines against similar viruses that have previously crossed over from animals to humans. The question is raised whether these viruses can be modified or adapted to combat the current virus. This research is being conducted globally, including in China.

We are in a digital and scientific revolution, hacking the software of life with mRNA. Our body is made of organs, organs of cells, and in each cell is messenger RNA transmitting DNA information to proteins. This "operating system" can be altered to impact diseases like the flu and cancer. For instance, instead of injecting virus proteins for a flu vaccine, mRNA instructions can teach the body to make its own protection. This mRNA technology has vast potential for disease prevention and treatment.

In this video, the speakers discuss the concept of self-spreading vaccines, which are genetically engineered to move through populations like communicable diseases. They highlight the potential risks and ethical concerns associated with this technology. The speakers also mention the government's involvement in funding and promoting these vaccines. They emphasize the importance of informed consent and express concerns about the potential consequences of releasing self-spreading vaccines on a global scale. The discussion raises questions about the safety and long-term effects of this technology. The speakers argue that the widespread use of self-spreading vaccines could infringe upon individual rights and lead to the suppression of dissenting voices.

The speaker claims mRNA is in the food supply. Merck has been injecting mRNA into pigs since 2018 with a product called Sequebiti. They claim to be able to make transmissible mRNA, meaning they can put it in an animal so that it transmits to whoever is ingesting it, effectively vaccinating them. The speaker suggests this could be engineered into plants and animals. Without informed consent laws, people who refused mRNA vaccines may get them through their food.

Transgenic lettuce is being developed to produce mRNA vaccines. The idea is to genetically engineer lettuce and spinach so that consuming them can provide vaccination against biological threats. However, there are scientific problems and potential health risks associated with this proposal. Moreover, it is part of a broader plan to bypass informed consent by incorporating mRNA gene technology into food. Another concerning concept is self-spreading vaccines, where respiratory viruses carry the vaccine and infect others. These proposals are seen as dangerous, reckless, and ethically and scientifically unsound.

In this video, the speakers discuss the potential of AI in speeding up the development of vaccines during future pandemics. They believe that if AI can reduce the time it takes to create a vaccine from a year to a month, it would be a significant advancement for humanity. However, one speaker expresses concerns about the implications of giving non-human entities the power to alter human biology and the potential dangers of experimental substances. Another speaker questions the decision to deploy AI without fully understanding its workings. They conclude by suggesting that the integration of artificial knowledge marks the beginning of a new era for humanity.